MedPath

华兰基因工程有限公司

Ownership
-
Established
2013-06-25
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Bevacizumab Injection

Product Name
安贝优
Approval Number
国药准字S20240051
Approval Date
Nov 15, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.